Crystal structure of human purine nucleoside phosphorylase at 2.3 Å resolution

被引:58
作者
de Azevedo, WF [1 ]
Canduri, F
dos Santos, DM
Silva, RG
de Oliveira, JS
de Carvalho, LPS
Basso, LA
Mendes, MA
Palma, MS
Santos, DS
机构
[1] UNESP, Dept Fis, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil
[2] Inst Butantan, Ctr Appl Toxicol, BR-05503900 Sao Paulo, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Mol Biol & Biotechnol, BR-91501970 Porto Alegre, RS, Brazil
[4] UNESP, Inst Biosci, Dept Biol, Lab Struct Biol & Zoochem CEIS, BR-13506900 Rio Claro, SP, Brazil
[5] Pontificia Univ Catolica Rio Grande do Sul, Fac Farm, Inst Pesquisas Biomed, Porto Alegre, RS, Brazil
基金
巴西圣保罗研究基金会;
关键词
PNP; synchrotron radiation; structure; drug design;
D O I
10.1016/S0006-291X(03)01431-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purine nucleoside phosphorylase (PNP) catalyzes the phosphorolysis of the N-ribosidic bonds of purine nucleosides and deoxynucleosides. In human, PNP is the only route for degradation of deoxyguanosine and genetic deficiency of this enzyme leads to profound T-cell mediated immunosuppression. PNP is therefore a target for inhibitor development aiming at T-cell immune response modulation and its low resolution structure has been used for drug design. Here we report the structure of human PNP solved to 2.3 Angstrom resolution using synchrotron radiation and cryocrystallographic techniques. This structure allowed a more precise analysis of the active site, generating a more reliable model for substrate binding. The higher resolution data allowed the identification of water molecules in the active site, which suggests binding partners for potential ligands. Furthermore, the present structure may be used in the new structure-based design of PNP inhibitors. (C) 2003 Published by Elsevier Inc.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 36 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Purine nucleoside phosphorylase from Mycobacterium tuberculosis.: Analysis of inhibition by a transition-state analogue and dissection by parts [J].
Basso, LA ;
Santos, DS ;
Shi, WX ;
Furneaux, RH ;
Tyler, PC ;
Schramm, VL ;
Blanchard, JS .
BIOCHEMISTRY, 2001, 40 (28) :8196-8203
[3]  
BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
[4]   Structure of human uropepsin at 2.45 Å resolution [J].
Canduri, F ;
Teodoro, LGVL ;
Fadel, V ;
Lorenzi, CCB ;
Hial, V ;
Gomes, RAS ;
Neto, JR ;
de Azevedo, WF .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2001, 57 :1560-1570
[5]   NUCLEOSIDES .5. SYNTHESIS OF GUANINE AND FORMYCIN-B DERIVATIVES AS POTENTIAL INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE [J].
CHERN, JW ;
LEE, HY ;
CHEN, CS ;
SHEWACH, DS ;
DADDONA, PE ;
TOWNSEND, LB .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (08) :1024-1031
[6]  
COOK WJ, 1981, J BIOL CHEM, V256, P4079
[7]   MULTIPLE SEQUENCE ALIGNMENT WITH HIERARCHICAL-CLUSTERING [J].
CORPET, F .
NUCLEIC ACIDS RESEARCH, 1988, 16 (22) :10881-10890
[8]   Molecular model of shikimate kinase from Mycobacterium tuberculosis [J].
de Azevedo, WF ;
Canduri, F ;
de Oliveira, JS ;
Basso, LA ;
Palma, MS ;
Pereira, JH ;
Santos, DS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (01) :142-148
[9]  
de Azevedo WF, 2002, BIOCHEM BIOPH RES CO, V293, P566
[10]   Molecular model for the binary complex of uropepsin and pepstatin [J].
de Azevedo, WF ;
Canduri, F ;
Fadel, V ;
Teodoro, LGVL ;
Hial, V ;
Gomes, RAS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (01) :277-281